Prelude Therapeutics, Inc. (PRLD)
3.75
+0.15
(+4.17%)
USD |
NASDAQ |
Nov 09, 16:00
3.75
0.00 (0.00%)
After-Hours: 19:48
Prelude Therapeutics Total Return Level : 3.60 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 3.60 |
| November 05, 2026 | 3.555 |
| November 04, 2026 | 4.08 |
| November 03, 2026 | 3.78 |
| November 02, 2026 | 3.84 |
| October 30, 2026 | 3.88 |
| October 29, 2026 | 4.10 |
| October 28, 2026 | 4.14 |
| October 27, 2026 | 3.88 |
| October 26, 2026 | 3.70 |
| October 23, 2026 | 3.63 |
| October 22, 2026 | 3.60 |
| October 21, 2026 | 3.65 |
| October 20, 2026 | 3.53 |
| October 19, 2026 | 3.39 |
| October 16, 2026 | 3.26 |
| October 15, 2026 | 3.32 |
| October 14, 2026 | 3.23 |
| October 13, 2026 | 3.56 |
| October 12, 2026 | 3.74 |
| October 09, 2026 | 3.89 |
| October 08, 2026 | 3.88 |
| October 07, 2026 | 3.83 |
| October 06, 2026 | 3.81 |
| October 05, 2026 | 3.77 |
| Date | Value |
|---|---|
| October 02, 2026 | 3.67 |
| October 01, 2026 | 3.79 |
| September 30, 2026 | 3.91 |
| September 29, 2026 | 3.96 |
| September 28, 2026 | 3.91 |
| September 25, 2026 | 3.875 |
| September 24, 2026 | 3.99 |
| September 23, 2026 | 4.31 |
| September 22, 2026 | 4.85 |
| September 21, 2026 | 4.70 |
| September 18, 2026 | 4.87 |
| September 17, 2026 | 4.57 |
| September 16, 2026 | 4.47 |
| September 15, 2026 | 4.52 |
| September 14, 2026 | 4.59 |
| September 11, 2026 | 4.59 |
| September 10, 2026 | 4.67 |
| September 09, 2026 | 5.09 |
| September 08, 2026 | 5.30 |
| September 04, 2026 | 5.46 |
| September 03, 2026 | 5.25 |
| September 02, 2026 | 5.43 |
| September 01, 2026 | 5.49 |
| August 31, 2026 | 5.60 |
| August 28, 2026 | 5.47 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Q32 Bio, Inc. | 9.25 |
| Intellia Therapeutics, Inc. | 11.35 |
| Twist Bioscience Corp. | 120.79 |
| Beam Therapeutics, Inc. | 26.41 |
| Revolution Medicines, Inc. | 192.28 |